Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fennec Pharmaceuticals (FENC) Gross Profit (2023 - 2025)

Historic Gross Profit for Fennec Pharmaceuticals (FENC) over the last 3 years, with Q3 2025 value amounting to $7.3 million.

  • Fennec Pharmaceuticals' Gross Profit rose 20560.47% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.3 million, marking a year-over-year decrease of 3465.67%. This contributed to the annual value of $29.1 million for FY2024, which is 4561.1% up from last year.
  • Latest data reveals that Fennec Pharmaceuticals reported Gross Profit of $7.3 million as of Q3 2025, which was up 20560.47% from $5.3 million recorded in Q2 2025.
  • Fennec Pharmaceuticals' Gross Profit's 5-year high stood at $20.2 million during Q1 2024, with a 5-year trough of $1.6 million in Q1 2023.
  • Its 3-year average for Gross Profit is $6.1 million, with a median of $5.3 million in 2025.
  • Its Gross Profit has fluctuated over the past 5 years, first skyrocketed by 117484.2% in 2024, then plummeted by 7122.17% in 2025.
  • Over the past 3 years, Fennec Pharmaceuticals' Gross Profit (Quarter) stood at $9.0 million in 2023, then plummeted by 56.01% to $4.0 million in 2024, then skyrocketed by 82.17% to $7.3 million in 2025.
  • Its Gross Profit was $7.3 million in Q3 2025, compared to $5.3 million in Q2 2025 and $5.8 million in Q1 2025.